Comparison of PREVENT with the pooled cohort equation for estimating atherosclerotic cardiovascular disease risk among patients with rheumatoid arthritis.

ABSTRACT:

Objective

To determine the performance of the PREVENT equation for estimating atherosclerotic cardiovascular disease (ASCVD) risk in rheumatoid arthritis (RA) compared to the American College of Cardiology/American Heart Association ASCVD risk estimator, i.e., the pooled cohort equation (PCE).

Methods

We studied patients from an RA longitudinal registry with annual blood samples. After identifying the earliest sample for each patient (index date), we excluded patients with prevalent cardiovascular disease (CVD) or on statin/lipid lowering therapy through the index date. Medical records were reviewed for ASCVD events including coronary heart disease and stroke up to 10 years after index date. PREVENT-ASCVD and PCE were calculated, and patients were categorized into low, borde

SUBMITTER: Usiskin IM 

PROVIDER: S-EPMC12615325 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature